IDENTIFICATION OF PROGNOSTIC FACTORS OF THE EFFICIENCY OF BEVACIZUMAB THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CANCER

<p><strong>Background.</strong> The design and introduction of novel medicaments into clinical practice has confirmed that it is necessary to search for new prognostic factors to re-evaluate the clinical and biological properties of a tumor and to identify a subgroup of patients wh...

Full description

Bibliographic Details
Main Authors:	B. Ya. Alekseyev, A. S. Kalpinsky, K. M. Nyushko, A. A. Klimenko, Yu. V. Anzhiganova, S. A. Varlamov, S. A. Bichurina, L. A. Vasilyev, A. V. Arkhipov, L. I. Gurina, O. V. Leonov
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Onkourologiâ
Subjects:	metastatic renal-cell cancer targeted therapy angiogenesis inhibitors prognostic factors bevacizumab Avastin
Online Access:	http://oncourology.abvpress.ru/index.php/oncur/article/view/111

by B. Ya. Alekseyev, A. S. Kalpinsky, K. M. Nyushko, A. A. Klimenko, Yu. V. Anzhiganova, S. A. Varlamov, S. A. Bichurina, L. A. Vasilyev, A. V. Arkhipov, L. I. Gurina, O. V. Leonov
Published 2014-07-01

Get full text

Article

IDENTIFICATION OF PROGNOSTIC FACTORS OF THE EFFICIENCY OF BEVACIZUMAB THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CANCER

Similar Items